encoded adenosine deaminase (ADA)into an oncolytic targeted herpes virus to improve enzyme secretion for the metabolism of adenosine, and the clearance of adenosine within the TME reversed HER2-positive breast cancer resistance to trastuzumab (139). This evidence concerns the gene ADA and breast cancer.